Grant supports use of data science to optimize HIV treatment monitoring

December 23, 2014

PROVIDENCE, R.I. [Brown University] -- HIV can be treated, but not every infection responds the same way. Treatment requires monitoring and testing, a practice that can become expensive for health care systems in the developing world. With a new grant from the National Institutes of Health, Brown University professors Joseph Hogan and Rami Kantor will lead an effort to develop data-driven techniques to improve the effectiveness of monitoring treatment and to maximize the benefits associated with using expensive diagnostic procedures.

Hogan, professor of biostatistics in the School of Public Health, and Kantor, associate professor of medicine at the Warren Alpert Medical School, will combine their expertise to develop statistical methods, software, and laboratory technologies that use clinical data from patient records to improve HIV treatment monitoring decisions. Their work will develop strategies to optimize timing and frequency of costly diagnostic procedures such as drug resistance testing and new methods for 'batch testing' to reduce the number of laboratory assays needed to determine individual patient viral loads.

In addition to developing the statistical framework and theory for these ideas, Hogan and Kantor will create practical laboratory methods and protocols that can be tested, refined, and implemented in AMPATH, a comprehensive HIV care program based in Eldoret, Kenya, that sees more than 130,000 HIV-infected patients a year.

Brown University is a member of the AMPATH Consortium, whose 18 North American institutions collaborate with Moi University in Eldoret on HIV research, care, and training. Hogan is co-director of biostatistics and Kantor is research director of the Brown University-Kenya Program. He studies the effectiveness of HIV treatment and its relationship to drug resistance.

Hogan said the project, supported with $3.5 million over five years, could demonstrate how more sophisticated use of data can improve medical care.

"This grant is emblematic of the emerging field of 'data science,' wherein new and innovative methods of statistical analysis and computing are directly motivated by and applied within a specific context," Hogan said. "Despite the fact that most of the world's people with HIV live in low- and middle-income countries, patients and doctors in places like Kenya do not have the resources needed to follow treatment guidelines that are used in the United States and Europe. The President's Emergency Plan for AIDS Relief, which funds many aspects of care in AMPATH, is narrowing this gap. We hope that projects like ours can help AMPATH and programs like it make the best use of the information and resources available to them."

Kantor said the work will produce not only academic but clinical benefits.

"It will combine multidisciplinary clinical, laboratory, and statistical expertise to improve care for HIV-infected patients in settings where physicians need to limit the tests they conduct for patient care due to infrastructure and resource constraints," said Kantor, who is also affiliated with the Lifespan health system. "Development of methods and close work with and training of clinicians and laboratory personnel in Kenya, as we propose to do, will impact patient care and optimize resource use."
In addition to Hogan and Kantor, the team includes Tao Liu, Allison DeLong, and Mia Coetzer of Brown, Michael Daniels of the University of Texas, and Lameck Diero, Wilfred Emonyi, and Ann Mwangi of Moi University in Eldoret.

Brown University

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to